Comparative Biosciences' Mission

• Toxicology
  • Regulatory
  • Discovery
  • Stem Cell
  • Botulinum
  • Investigative-Special-Custom
• Pharmacokinetics
• Pharmacology
  • Ocular
  • Cardiovascular
  • Inflammation
  • Atherosclerosis
  • Arthritis-Immune Mediated
  • Metabolic and Bone
  • Anti-infective
  • Oncology
  • Stem Cell
  • Botulinum
  • Surgical-Custom-Special
• Dermatology
  • Toxicology Studies
  • Pharmacokinetics or Bioavailability Studies
  • Pharmacology and Efficacy Studies
• Ocular
  • Ocular Toxicology
  • Ophthlamic Pharmacokinetics
  • Ophthlamic Pharmacology & In Vivo
• Stem Cells
• Botulinum
• Histopathology
  • Laboratory Capabilities
  • Histochemical Staining
  • Pathology
  • Confocal Microscopy
  • Toxicology
  • Tissue Cross Reactivity
  • Immunohistochemistry
  • Devices, plastics, ground sections
  • Histomorphometry
  • Specialized Histology
  • Submitting a Study
  • Fee Schedule
  • Slide Gallery
• About CBI
  • Management Team
  • Scientific Advisors
  • Scientific Staff
  • Mission
  • Careers
  • Partners
  • Contact Us
• Events
• News
• Publications

Comparative Biosciences’ mission is to provide the best quality preclinical laboratory services to our clients in the biopharmaceutical and medical device industries on the West Coast and beyond. This mission will be achieved through our commitment to customer service, scientific quality, and employee satisfaction. Accomplishment of our mission will result in the long-term growth of Comparative Biosciences, the creation of value for all stakeholders in our company, success for our clients, and better health for humans and animals worldwide.